Download Life Members - AAISCR.....

Life Members
Life Members & Contact
Bharat B. AGGARWAL, Ph.D. (U.C., Berkeley)
Founding Director, Anti-inflammation Research Institute,
San Diego, California; USA
Former Professor of Experimental Therapeutics, Cancer
Medicine and Immunology,
The University of Texas M. D. Anderson Cancer Center,
Houston, Texas
Phone: 832-754-0059; Email: [email protected]
Research Interest &
Hobbies
Inflammation and cancer,
cytokines, NF-kβ
Dr. Ram P. AGARWAL
Professor
University of Miami Medical Center
Miami, FL
[email protected]
Krishna C. AGRAWAL, Ph.D. (Deceased)
Regents Professor and Chairman
Department of Pharmacology
Tulane University School of Medicine
New Orleans, LA 70112
Dr. Shrikant ANANT
Professor of Molecular and Integrative Physiology and
Surgery
University of Kansas Medical Center
Kansas
[email protected]
Thiru ARUMUGAM, Ph.D.
Senior Research Scientist
Dept of Cancer Biology
UT MD Anderson Cancer Center, Houston, TX-77030
[email protected];
[email protected]
Dr. Shilpi ARORA
Scientist
Constellation Pharmaceuticals
Boston, MA
[email protected]
Dr. Shubha BAGRODIA
Scientist
Pfizer
San Diego, CA
[email protected]
Dr. Hamid BAND
Elizabeth Bruce Professor of Cancer Research at Eppley
Institute, and associate director of translational research at
the Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, NE
[email protected]
Interest in understanding
the mechanisms that
regulate gene expression at
the posttranscriptional
levels of mRNA stability
and translation during
tumorigenesis
Research Interests:
Pancreatic Cancer,
Chemoresistance,
Bioinformatics
Hobbies: Reading, Music
Cancer genetics
Regulation of tyrosine
kinase-mediated cell
signaling with the longterm goal of developing
targeted therapeutics and
early
diagnostic/prognostic
markers for cancer
Dr. Vimla BAND
Ardith & Anna Von Housen Professor
Chair, Department of Genetics, Cell Biology & Anatomy
Associate Director of Center for Breast Cancer Research
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, NE
[email protected]
Dr. Prashant BAVI, M.D.
Postdoctoral Fellow
Dept Of Human Cancer Genomic Research
[email protected];
[email protected]
Website: http://www.linkedin.com/in/prashantbavi
Dr. Surinder K. BATRA
Professor & Chairman Department of Biochemistry and
Molecular Biology, College of Medicine, StokesShackelford Professor, Associate Director for Education
and Training, Fred & Pamela Buffett Cancer Center,
Eppley Institute for Research in Cancer
University of Nebraska medical center
Omaha, NE
Email: [email protected]
Delineate molecular
mechanisms of early steps
in transformation of
mammary epithelial cells
with the goal of
identifying novel
molecular
diagnostic/prognostic
markers and potential
therapy targets of breast
cancers
Research Interests
Oncopathology: Colorectal
Cancer and Thyroid
Cancer,
validation of biomarkers,
improving efficacy of
tissue microarray
technology, Image
analysis, and tumor
biobanking
Tumor-associated genes;
cancer diagnostics, cancer
vaccines; monoclonal
antibodies, genetic
engineering of antibodies
Dr. Kapil N. BHALLA, M.D., F.A.C.P.
Professor, Department of Leukemia, Division of Cancer
Medicine
The University of Texas MD Anderson Cancer Center,
Houston, TX
[email protected]
Targeted Therapy for
AML Stem Cells
Dr. Subhash CHAKRABARTY
Professor
Depart. of Microbiology, Immunology & Cell Biology
Simmons Cooper Cancer Institute
Southern Illinois University School of Medicine
Springfield, Illinois 62794‐9677
[email protected]
Dr. Dhrubajyoti CHAKRAVARTI, Ph.D.
Chief Scientist
4115 Harrison St, Bellevue, NE 68147
[email protected]
Mechanisms of growth and
differentiation control in
epithelial cancer.
Website: http://www.life-120.com/
Research Interests:
Identify and develop
natural and synthetic
compounds that provide
protection against
environmental pollution.
Hobbies: Photography
Dhyan Chandra, Ph.D. (JNU, India)
Associate Professor
Dept. of Pharmacology & Therapeutics
Roswell Park Cancer Institute,
Elm & Carlton Streets,
Buffalo, NY14263
[email protected]
Dr. Bakul I. DALAL, M.D., FRCP
Hematopathologist
Vancouver General Hospital
Clinical Professor, University of British Columbia
Vancouver Coastal Health
11Th Floor 601 West Broadway
Vancouver, British Columbia V5Z 4C2
Canada
[email protected]
Chandradhar DWIVEDI, Ph.D. (Lucknow University)
University)(Retired)
Distinguished Professor and Head,
Department of Pharmaceutical Sciences
College of Pharmacy, South Dakota State University,
Brookings, SD 57007
[email protected]
Dr. Rama S. DWIVEDI
Northwestern University
Chicago, IL
[email protected]
Dr. Sanjiv Sam GAMBHIR
Virginia and D.K. Ludwig Professor for Clinical
Investigation in Cancer Research
Chair, Department of Radiology
Stanford University School of Medicine
Stanford, CA
[email protected]
Dr. Varsha GANDHI
Department of Experimental Therapeutics
UT M.D. Anderson Cancer Center
1515 Holcombe Blvd., Houston, TX 77030
[email protected]
Dr. Aniruddha GANGULY
National Cancer Institute
Bethesda, MD
[email protected]
Research Interest:
Apoptosis signaling,
cancer stem cells
Hematopathology
Research Interest- Cancer
prevention and treatment
Hobbies- Reading,
spirituality, listening to
music, gardening
Radiology/Nuclear
Medicine; developing
imaging assays to monitor
fundamental
cellular/molecular events
in patients; positron
emission tomography
(PET), optical
(fluorescence,
bioluminescence, Raman),
ultrasound, and
photoacoustic imaging are
focus of investigation
Experimental therapeutics
Mechanisms of tumor
development & metastasis,
tumor microenvironment,
brain tumor biology,
cancer diagnostics,
molecular analysis
technologies for cancer
research
Dr. Ramesh GANJU
Scott Endowed Chair and Professor
Vice Chair, Experimental Pathology
810 Biomedical Research Tower
460 West 12th Avenue
Columbus, OH 43210
[email protected]
Dr. Rita GHOSH
Associate Professor
Department of Urology
The University of Texas Health Science Center at San
Antonio
7703 Floyd Curl Drive, Mail Code 7845
San Antonio, Texas 78229-3900
Phone: (210) 567-5664
[email protected]
Dr. Rayudu GOPALKRISHNA
Associate Professor
Cell and Neurobiology
Keck School of Medicine
University of Southern California
Health Sciences Camous
Los Angeles, CA 90089-9112
[email protected]
Dr. Sushovan GUHA, M.D., Ph.D.
Gastroenterologist
Houston, TX 77030
Phone: (713) 704-4000
E-mail: [email protected]
Role of chemokines, and
various inflammatory
molecules, and antiinflammatory molecules,
in pathogenesis of various
diseases
Study on deregulation of
DNA damage signaling
and cell cycle progression
in cancer and use these
pathways as molecular
targets to develop
strategies for cancer
prevention and or therapy
Prostate cancer prevention
Research Interests: Novel
signal transduction
pathways in GI cancers
and chemoprevention of
GI cancer
Dr. Rishab K. GUPTA
Wayne Cancer Institute, CA
[email protected]
Dr. Shanker L. GUPTA
Program Manager
Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Bethesda, MD
[email protected]
Dr. Sudhir GUPTA, M.D.
Professor
[email protected]
Anti-cancer drug
development
Molecular signaling in
apoptosis
Memory CD4+ and CD8+
T cells
Dendritic cell functions
Dr. Surendra GUPTA, Ph.D.
President
American Radiolabeled Chemicals, Inc.
Email: [email protected]
Website: www.arc-inc.com
Radiopharmaceuticals
Dr. Abid HUSSAIN
Dr. H.N. JAYARAM
Professor
Indiana University, IN
[email protected]
Dr. Madhavi KADAKIA
122 Diggs Laboratory
Dept. of Biochemistry & Molecular Biology
Wright State University
Dayton, OH 45435
[email protected]
Dr. Hari KAUL, Ph.D., FACN
Carroll W. Feist Endowed Chair
Professor & Chairman
Department of Biochemistry & Molecular Biology
School of Medicine LSUHSC- shreverport, LA
Associate Director, Feist Weiller Cancer Center
Phone (office):318-675-5161
[email protected]
Dr. Meena KATDARE, (University of Pune, India,
1978)
Director, Carcinogenesis and Chemoprevention
Laboratory
Weill Cornell Medical College
1300 York Avenue, Box-287, New York, NY 10021
Ph: 212-746-5431 - [email protected]
http://www.cornellsurgery.org/pro/research/biosketches.ht
ml
Dr. Koyamangalath KRISHNAN, MD, FRCP, FACP
Dishner Endowed Chair of Excellence in Medicine
Professor of Medicine
Division Chief of Hematology/Oncology
Department of Clinical Cancer Prevention, Division of
Cancer Prevention and Population Sciences,
The UT MD Anderson Cancer Center, Houston, TX
77030
[email protected]
Dr. Raju KUCHERLAPATI
Paul C. Cabot Professor, Department of Genetics,
Harvard Medical School
Professor, Department of Medicine
Scientific Director, Harvard-Partners Center for Genetics
and Genomics, Partners Healthe Care System, Brigham
and Women's Hospital
Boston, MA
[email protected]
Research Interests: Signal
transduction pathways of
carcinogenesis and
chemoprevention
of breast, colon, prostate
and thyroid cancers
Hobbies: Gardening,
Interior Decoration,
Knitting, Dress designing,
Travel, Indian Music
Cloning and
characterization of human
disease genes with a focus
on human syndromes with
a significant
cardiovascular
involvement; use of
genetic/genomic
approaches to understand
the biology of cancer and
the generation and
characterization of
genetically modified
mouse models for cancer
and other human disorders.
Dr. Rakesh KUMAR
Professor
Biochemistry and Molecular Biology
George Washington University School of Medicine
Washington, DC
[email protected]
Dr. Shaji KUMAR, (M.D.)
Associate Professor
Mayo Clinic, Rochester, MN 55905
[email protected]
Dr. Aroop MANGALIK, M.D.
Hematology
900 Camino de Salud NE
1 University of New Mexico
Albuquerque, NM 87131
Dr. Kapil MEHTA, (Ph.D., PGI, Chandigarh, India)
Director R&D, Molecular Quest-Personalized Medicine
Adjunct Professor, Department of Biochemistry and
Molecular Biology, The University of Maryland School
of Medicine, Baltimore, MD
Former Professor of Cancer Medicine (Biochemistry)
Univ of Texas M. D. Anderson Cancer Center
Houston, TX 77030
Email: [email protected]
Research Interests:
Interactions between
malignant plasma cells
and the marrow
microenvironment in
plasma cell malignancies;
develop new therapeutic
approaches to target these
interactions and enhance
the efficacy of the
currently available
therapies.
Research interests:
Chemoresistance,
metastasis,
retinoids, drug delivery
systems
Hobbies: Reading,
gardening, music
Rajendra G. MEHTA, Ph.D.
Assistant Vice President, Professor and Head
IIT Research Institute and IIT
Chicago, IL 60616
[email protected]
Research Interests:
Efficacy and molecular
mechanism(s) of action of
chemopreventive
agents including Vitamin
D and Resveratrol in
breast, colon and lung
cancer models.
Dr. Krishna MENON
Scientist/Business owner
Cell Centix Inc.
Beverly, MA
[email protected]
In vivo and vitro
preclinical testing
Dr. Lopa MISHRA (M.D.)
Chair, Gastroenterology, Hepat. & Nutrition
MD Anderson Cancer Center
1515 Holcombe Blvd
Houston, TX 77030
Email: [email protected]
Gastroenterology
Dr. Sankar Mitra
Full Member, Professor of Radiation Oncology, Institute
for Academic Medicine
Houston Methodist Research Institute
Houston, TX
[email protected]
Genome damage, its
repair, and its influence in
carcinogenesis and cancer
therapy; recent research
focus is on enhancement of
chemo/radiation sensitivity
of tumor cells using
targeted DNA repair
inhibitors; following his
early studies with MGMT
inhibition, his current
research aims to identify
inhibitors for repair
pathways for
oxidative/radiation damage
HIV-1 induced
pathogenesis; role of HIV1 transactivator (Tat)
protein in regulating viral
latency and infectivity;
pharmacological
interventions to enhance
efficacy and reduce toxic
side effects of antiretroviral drugs
Molecular target based
approaches for prevention
and treatment of cancer
and skin disease psoriasis
by phytochemicals
Dr. Debasish MONDAL
Associate Professor
Department of Pharmacology
Tulane University
New Orleans, LA
[email protected]
Dr. Hasan MUKHTAR
Professor
Department of Dermatology
University of Wisconsin
School of Medicine & Public Health
Madison, WI
[email protected]
Dr. Anuradha MURALI
Microbiology and Immunology
Medical University of South Carolina
Charleston, USA
[email protected]
Dr. Harikrishna NAKSHATRI
Marian J. Morrison Professor of Surgery
Indiana University School of Medicine
Indianapolis, IN
[email protected]
Dr. Pratima NANGIA-MAKKER
Assistant Professor
Wayne State University, Detroit, MI 48201
[email protected]
Dr. Satyabrata NANDI (Retired)
Professor Emeritus of Cell & Developmental Biology
University of California, Berkeley, CA
[email protected]
Dr. Shanker NAYAK
(Diseased)
Director, Diagnostics
Hoag Cancer Center
New Port Beach, CA
Dr. Arokya Mary S. PAPU JOHN
Postdoctoral Research Associate
Biomedical & Diagnostic Sciences
University of Tennessee
Knoxville, TN
[email protected]
Activation of NF-kB in
estrogen receptor negative
breast cancer. The focus is
on genomic aspects of
anti-estrogen resistance,
mechanisms of organspecific metastasis and
biomarkers of breast
cancer progression and
therapeutic response
Research Interests: Role
of carbohydrate-binding
protein galectin-3 in
cancer progression and
metastasis. We are also
studying the inhibitory
effects of natural plant
products on cancer
progression
Determine the biological
and molecular bases for
susceptibility and
resistance to breast
carcinogenesis as well as
for the prevention of breast
cancer
Gene vaccine therapy,
Preclinical cancer research
Cancer Diagnostics
Dr. Sen PATHAK (Retired)
Former Professor
Cytogenetics
MD Anderson cancer Center
Houston, TX
[email protected]
Cancer cytogenetics
Dr. Subbarayan R POCHI (Ph.D., Banaras Hindu
University, 1994)
Research Assistant Professor
Department of Medicine
Division of Hematology and Oncology
University of Miami Miller School of Medicine
Research Interests: 5FU
resistance,
Pharmocogenomics, Ethno
botanicals
Hobbies: Reading,
Traveling by road,
Miami, FL - 33176
Community work.
Dr. Raj PURI, M.D., Ph.D.
Division Director, Food and Drug Administration,
Bethesda, MD
[email protected]
Dr. Govind RAGUPATHI
Associate Attending Immunologist
Memorial Sloan-Kettering Cancer Center
New York, NY 10065
Tel: (646) 888 2363
Fax: (646) 422 0516
E-mail: [email protected]
Develop monoclonal
antibodies, optimize
vaccines that induce
antibody responses, and
produce and test new
immunological adjuvants
to augment these responses
Dr. Ranju RALHAN
Department of Pathology and Laboratory Medicine
Joseph & Wolf Lebovic Health Complex
Mt. Sinai Hospital
600 University Ave., Room 6-416
Toronto, ON M5G 1X5
[email protected]
Translational cancer
research, molecular
diagnostics proteomics,
genomics, epigenomics,
cancer biology, cell
biology, targeted therapy
Dr. Chandra RAMANATHAN, Ph.D., MBA
Scientist, Head Early Pipeline Oncology
Bayer HealthCare Pharmaceuticals
West Haven, Connecticut 06516
[email protected]
Dr. Aramandla RAMESH
Associate Professor
Biochemistry & Cancer Biology
Meharry Medical College
Nashville, TN
[email protected]
Dr. Pranela RAMESHWAR
Professor
Department of Medicine
Division of Hematology-Oncology
Rutgers, The New Jersey Medical School
Newark, NJ
Telephone: (973) 972 0625
[email protected]
Dr. Kaladhar B. REDDY
Professor
Wayne State University School of Medicine
540 East Canfield Avenue
Detroit, MI 48201
[email protected]
Environmental
Toxicology, Chemical
Carcinogenesis
Cancer stem cell research;
breast cancer dormancy in
bone marrow; immune
protection of specific
breast cancer cell subsets
by mesenchymal stem
cells; neural-hematopoietic
axis
Novel strategies for
treatment and prognosis of
breast cancer by
combining experimental
therapeutics with cell
biology; cancer stem cells
Dr. Shrikanth REDDY
Department of GI Med Oncology
MD Anderson Cancer Center
1515 Holcombe Blvd
Box 0956
Houston, TX 77030
[email protected]
Dr. Fazlul SARKAR
Distinguished Professor
Department of Pathology
Karmanos Cancer Institute
Detroit, MI
[email protected]
Dr. D. S. R. SARMA (Retired)
Former Professor
University of Toronto, Canada
[email protected]
Dr. Anjana SAXENA, Ph.D.
Associate Professor
Biology
Brooklyn College
City University of New York, NY
Phone: 718.951.5000 x2671
Email: [email protected]
Role of NF-κB and its
signaling molecules in
solid tumors, and in
elucidating the molecular
mechanisms of action of
“natural agents” for cancer
prevention and therapy
Studies nucleolar stress
factors (NSFs) and their
role/s in regulating cell
cycle under normal
conditions and during
cellular responses to DNA
damage.
Dr. Neeraj SAXENA
Assistant Professor
University of Maryland School of Medicine
Baltimore, MD
[email protected]
Links between obesity,
adipocytokines and
carcinogenesis
Dr. Senthamil SELVAN
Vice-President R&D
Omni Array Biotechnology
15601 Crabbs Branch Way
Rockville, MD
[email protected]
Dr. Subrata SEN
Professor & Deputy Chair, Department of Translational
Molecular Pathology, Division of Pathology/Lab
Medicine, The University of Texas MD Anderson Cancer
Center, Houston, TX
Phone: (713) 834-6040
Email: [email protected]
Cancer Immunotherapy
Dr. Shyam SHARAN
Deputy Program Director, Mouse Cancer Genetics Prog.
Senior Investigator
Head, Genetics of Cancer Susceptibility Section
Center for Cancer Research
National Cancer Institute, Frederick, MD
[email protected]
Functional characterization
of the genes regulating
mitotic chromosome
segregation and
elucidation of their role in
the induction of
chromosomal instability in
cancer
DNA repair, hereditary
Breast cancer, tumor
suppressor, mouse models,
recombineering, BRCA1/2
variants
Dr. Dipali SHARMA
Associate Professor of Oncology
Kimmel Cancer Center
Johns Hopkins University
Baltimore, MD
[email protected]
Dr. Zahid H. SIDDIK
Scientist
UTMD Anderson Cancer Center
Houston, TX
[email protected]
Garima SINHA
Graduate Student
Rutgers Biomedical Health Sciences
Rutgers,
rs, The State University of New Jersey
Newark, NJ
[email protected]
Breast Cancer, ObesityCancer Connection,
Adipocytokines,
Metastasis, Tamoxifen
Resistance, Novel
Therapeutics, Bioactive
Food Components,
Signaling Mechanisms
Cancer stem cell research;
intercellular
communication in cancer
stem cells
Dr. Promila SINGH
Professor
Department of Biochemistry & Molecular Biology
University of Texas Medical Branch
Galveston, TX
[email protected]
Dr. Sujay SINGH
President and CEO
ABGENEX Corp.
San Diego, CA
[email protected]
Cancer diagnostics,
Biotechnology
development
Dr. Keshav K. SINGH
Professor of Oncology
Roswell Park Cancer Institute
Buffalo, NY, 14263
Research Interest: Role
of mitochondria in
cancer, Inter genomic
crosstalk and its role
tumorigenesis and
mitochondrial diseases
Hobbies: Kite flying,
traveling
Research Interests: Breast
cancer model systems,
molecular mechanisms of
prevention in breast and
prostate cancers.
www.keshavsingh.org
Dr. Raghu SINHA (Ph.D., PGIMER, Chandigarh, India)
Associate Professor
Penn State College of Medicine, Hershey, Pennsylvania
Website link:
http://fred.psu.edu/ds/retrieve/fred/investigator/rus15
[email protected]
Dr. Taduru SREENATH
Assistant Director, CPDR Basic Science Research
Program,
The Henry M. Jackson Foundation
Research Assistant Professor of Surgery
USUHS
[email protected]
Scientific interests focus
on understanding
molecular mechanisms
underlying prostate cancer
initiation and development
using mouse models
Dr. Saraswati SUKUMAR
Barbara B. Rubenstein Professor of Oncology
Johns Hopkins University School of Medicine, Baltimore,
MD21231
[email protected]
Dr. Rajeshwar Rao TEKMAL
Carl J. Pauerstein Professor in Reproductive Research,
Director, Division of Reproductive Research
Department of Obstetrics and Gynecology
University of Texas Health Science Center at San Antonio
San Antonio, TX 78229-3900
Tel: 210-567-4930; Direct: 210-567-4935
[email protected]
Dr. Nityanand T. TELANG
Roswell Park Cancer Institute
Buffalo, NY
[email protected]
Dr. T. J. THOMAS
Professor
R.W. Johnson Medical Center
Rutgers University, NJ
[email protected]
[email protected]
Dr. Meghana TRIVEDI
Assistant Professor
Department of Pharmacological and Pharmaceutical
Sciences
University of Houston College of Pharmacy
Texas Medical Center Campus
Houston, Texas 77030
Ph. 832-842-8335
[email protected]
Dr. Ratna K. VADLAMUDI
Professor
Department of Obstetrics & Gynecology
UTHSCSA, San Antonio, TX
[email protected]
Ph. (210) 567-4930
Dr. Hariprasad VANKAYALAPATI
Scientist/Medicinal chemist
Draper, UT
[email protected]
[email protected]
Research Interests:
Discovery and study of
molecular alterations in
breast cancer. Methods and
markers for early detection
and prognosis.
Role of hormones
and growth factors and
their receptors in the
initiation and progression
of breast,
cervical and ovarian
cancers.
Develop novel DNA
delivery vehicles for gene
therapy. The current focus
is on breast cancer
G-protein coupled receptor
targets in cancer treatment;
drug discovery for novel
targets and test drug
efficacy to predict
treatment outcomes;
cellular signaling of
proteins targeted by drugs;
identification of genetic,
cellular, and circulating
biomarkers to predict
outcome of
pharmacological treatment
in cancer patients
Research Interests:
Estrogen signaling,
Hormonal therapy
resistance, Nuclear
receptors, Signal
transduction, Tg/KO
mouse models for cancer
Dr. Atul VARADHACHARI, M.D.
President & Chief Operating Officer
Agennix, Inc., Houston, TX
[email protected]
Dr. Arti PATEL VARANASI,, Ph.D., M.P.H.
President & CEO
Advancing Synergy, LLC
1450 South Rolling Road
Baltimore, MD 21227
www.advancingsynergy.com
[email protected]
Siva VENUGOPAL
Sugar Land, TX
Engineering/bioinformatics company owner
[email protected]
Dr. Inder VERMA
Professor
Laboratory of Genetics
American Cancer Society Professor of Molecular Biology
Irwin and Joan Jacobs Chair in Exemplary Life Science
The Salk Institute for Biological Studies
La Jolla, CA
[email protected]
Dr. Ajit K. VERMA (Univ of South Australia,
Adelaide)
Professor, University of Wisconsin
Madison, WI 53792
weblink: www.med.wisc.edu/metc/fac/fac53.php.
E-mail: [email protected]
Dr. Meena VORA
Scientist/Business owner
Biosphare
Fremont, CA
[email protected]
Cancer research, public
health, advocacy, capacity
building and project
management
Gene therapy for cancer;
developed viruses for gene
therapy vectors; developed
a gene therapy vector,
based on a stripped-down
version of HIV, that can
deliver genes to nondividing cells, which
constitute majority of the
cells in our bodies.
Research interests:
etiology and prevention of
skin and prostate cancer.
PKCepsilon signal
transduction pathways
Hobbies: fishing and
gardening.
Dr. Mansukh WANI
Principal Scientist (Retired)
Research Triangle Institute, NC 27709
www.rti.org/naturalproducts
[email protected]
Research Interests:
Discovery of Anticancer
Agents of Diverse Natural
Origin